BCL2L1 and systemic sclerosis: To explore how the BMPRII signalling pathway protects the cells from apoptosis, normal-MVECs and SSc-MVECs were treated with BMP2 (200 ng/ml) for 24 hrs, and Bcl-xL mRNA expression was measured by qPCR.